Navigation Links
Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
Date:1/30/2009

NEWARK, Del., Jan. 30 /PRNewswire/ -- The Center for Molecular Biology (CMB) has received an $8.7 million grant from the Bill & Melinda Gates Foundation to support continued development of an avian influenza vaccine that uses transient plant-based technology. CMB will develop vaccines against highly pathogenic avian influenza viruses of H5N1 subtype, and work to advance promising candidates into clinical trials.

Dr. Vidadi Yusibov, CMB's Executive Director said, "CMB's vaccine technology has the potential to revolutionize how vaccines are manufactured, allowing for a more rapid and affordable response to pandemic flu threats."

"It is essential that new vaccines reach the people who need them most," said Doug Holtzman, Senior Program Officer for the Bill & Melinda Gates Foundation. "If successful, this project could help developing countries respond quickly to outbreaks of influenza and other infectious diseases to significantly limit their impact on vulnerable populations."

CMB's platform provides a new alternative to traditional vaccine production, with improved speed, surge capacity, and cost efficiency. The technology has also earned support from the Defense Advanced Research Projects Agency (DARPA) to continue developing the technology and establish it as a platform for accelerated manufacturing pharmaceuticals. The transient plant- based expression technology is licensed by CMB from its partner, iBioPharma, Inc.

About Fraunhofer Center for Molecular Biotechnology

Fraunhofer CMB's mission is to develop safe and effective vaccines targeting infectious diseases and autoimmune disorders. CMB's technology provides a safe, rapid and economical alternative for vaccine production. The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge technologies to assist the diagnosis, prevention and treatment of human and animal diseases. The Center houses individuals with expertise and excellence in plant virology, pathology, molecular biology, immunology, vaccinology, protein engineering, and biochemistry. Further information is available at www.fraunhofer-cmb.org

Fraunhofer CMB is one of six Fraunhofer USA research centers. Fraunhofer USA, Inc. is a non-profit research and development corporation, with headquarters in Michigan. It operates through technology centers that are partnered with major research universities in the United States and also with parent research institutes in Germany. Fraunhofer USA is a wholly-owned subsidiary of Fraunhofer Gesellschaft which promotes and undertakes applied research in an international context, of direct utility to private and public enterprise and of wide benefit to society as a whole.

    Contact:
    Dr. Vidadi Yusibov, Executive Director
    Fraunhofer CMB
    (302) 369-3034

'/>"/>
SOURCE Fraunhofer Center for Molecular Biotechnology
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Fraunhofer and Boston University Hosted Prestigious SME Tour
2. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
3. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
4. Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany
5. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
6. Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease
7. Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology
8. NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas
9. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
10. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
11. St. Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 , ... ... product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is ... fully 21 CFR Part 11-compliant email client designed to provide product vigilance departments ...
(Date:1/19/2017)... Jan. 19, 2017  ArmaGen, Inc., today announced ... Ph.D., as chief executive officer, as well as ... brings to ArmaGen more than 17 years of ... development of biotherapeutics and pharmaceuticals. ... diverse experience and skillset necessary to lead ArmaGen ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical Informatics Association ... Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data sharing plans ... policy. AMIA recommended that NIH earmark funding for researchers to produce and execute ...
(Date:1/19/2017)... ... , ... FireflySci Inc. is a go-getter type of company that continues to ... two main factors. The first is the amazing customer service that the FireflySci ... all around the world. , 2016 was a tremendous sales year for FFS and ...
Breaking Biology Technology:
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
(Date:1/6/2017)... Jan. 5, 2017  SomaLogic announced today that ... Alliance" established by iCarbonX, the China ... a "Global Digital Health Ecosystem that can define ... of individual,s biological, behavioral and psychological data, the ... the companies, SomaLogic will provide proteomics data and ...
(Date:12/22/2016)... VIEW, Calif. , Dec. 20, 2016  As part ... levels, 23andMe, the leading personal genetics company, recently released its ... Me . The book focuses on the topics of ... Next Generation Science Standards (NGSS) taught in elementary school classrooms ... second in a series by illustrator Ariana Killoran , ...
Breaking Biology News(10 mins):